Impulse Dynamics

Continued Expansion for Impulse Dynamics’ Optimizer™ IVs Device – First Implant in the Emirate of Sharjah (UAE)

Impulse Dynamics
November 11, 2015


Continued Expansion for Impulse Dynamics’ Optimizer™ IVs Device – First Implant in the Emirate of Sharjah (UAE)

Stuttgart, Germany, November 11th, 2015 – Impulse Dynamics reported today the first implantation of its Optimizer IVs device in the Emirate of Sharjah (UAE). The Optimizer IVs is a minimally invasive implantable device designed to treat Chronic Heart Failure (CHF). The device is based on novel Cardiac Contractility Modulation (CCM) technology, and delivers non-excitatory electric pulses. The implantation took place at the Cardiac Center of Al Qassimi Hospital, which is the largest public hospital in the Sharjah emirate, performed by Dr. Mohamed Magdy, Chairman & Director GULF EP Live and Head of the EP department, Cardiac Center and Dr. Arif Al Nooryani, CEO and Head of the Cardiology department, and his team.

“The introduction of CCM in the Emirate of Sharjah (UAE) is a significant milestone for our commercial expansion in the Middle East” said Dr. Simos Kedikoglou, CEO of Impulse Dynamics. “CCM is a well-established technology that meets a major need globally.”

Dr. Magdy & Dr. Al Nooryani commented: “We are very pleased that we can now offer the Optimizer system to our heart failure patients. The CCM therapy will address those patients with symptomatic heart failure and narrow QRS complex despite pharmacological therapy for whom there is no other device based alternatives, and will provide these patients with a new therapeutic option.



About the Optimizer and CCM Therapy
CCM is the brand name for Cardiac Contractility Modulation, the non-excitatory electrical pulses delivered by the implantable Optimizer device during the absolute refractory period of the heart’s cardiac cycle to improve systolic contraction of the heart. The Optimizer System has been implanted in over 4,000 patients and is currently available in the US, Europe, China, Brazil, India, and more than 40 other countries around the world. Impulse Dynamics has completed numerous clinical studies, including several randomized controlled trials, and the results have been published in over 80 articles appearing in leading medical journals.


About Impulse Dynamics
Impulse Dynamics is a medical device company dedicated to transforming the treatment of chronic heart failure. With global headquarters in Mount Laurel, N.J., the company has additional offices in; Stuttgart, Germany, Orangeburg, N.Y. and Curacao For more information please visit

Impulse Dynamics (USA), Inc.
523 Fellowship Road, Suite 203
Mt. Laurel, NJ 08054